DeepMed Research

UNIVERSITY OF ARIZONA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-01-01

Employees: 10K

Market Cap: -

Website: http://www.arizona.edu

Clinical Trials

Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy

Early Phase 1

Terminated

Conditions: Head and Neck Cancer
Salivary Gland Dysfunction
Xerostomia

Interventions: Drug: Everolimus
Other: Laboratory Biomarker Analysis
Other: Survey Administration

First Posted Date: 2018-07-06

Last Posted Date: 2019-12-02

Lead Sponsor: University of Arizona

Target Recruit Count: 2

Registration Number: NCT03578432

Locations: 🇺🇸
The University of Arizona Cancer Center, Phoenix, Arizona, United States

Investigational Test of a New Sleep Supplement

Not Applicable

Completed

Conditions: Sleep
Mood
Cognitive Performance

Interventions: Other: Control
Dietary Supplement: Proprietary Spearmint Extract Blend

First Posted Date: 2018-06-25

Last Posted Date: 2024-07-18

Lead Sponsor: University of Arizona

Target Recruit Count: 105

Registration Number: NCT03567343

Locations: 🇺🇸
University of Arizona Dept of Psychiatry Research facilities, Tucson, Arizona, United States

Multi-center:The Small (14F) Percutaneous Catheter vs. Large (28-40F) Open Chest Tube for Traumatic Hemothorax (P-CAT)

Not Applicable

Completed

Conditions: The Efficacy of Percutaneous Catheter vs. Open Chest Tube
Traumatic Hemothorax

Interventions: Device: Percutaneous catheter

First Posted Date: 2018-06-06

Last Posted Date: 2021-05-03

Lead Sponsor: University of Arizona

Target Recruit Count: 61

Registration Number: NCT03546764

Locations: 🇺🇸
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
🇺🇸
University of Ariznoa Medican Center, Main campus, Tucson, Arizona, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 1 locations

Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders

Not Applicable

Active, not recruiting

Conditions: Anxiety
Substance Abuse
Depression
Insomnia

Interventions: Device: TES Treatment
Device: TES-SHAM Treatment

First Posted Date: 2018-05-30

Last Posted Date: 2018-10-11

Lead Sponsor: University of Arizona

Target Recruit Count: 14

Registration Number: NCT03540745

Locations: 🇺🇸
Carrier Clinic, Belle Mead, New Jersey, United States

T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer

Phase 2

Completed

Conditions: HER2 Positive Breast Carcinoma
HER2-positive Breast Cancer
Breast Cancer
Breast Cancer Stage
Recurrent Breast Cancer
Metastatic Breast Cancer

Interventions: Drug: Palbociclib
Drug: T-DM1

First Posted Date: 2018-05-21

Last Posted Date: 2024-08-13

Lead Sponsor: University of Arizona

Target Recruit Count: 55

Registration Number: NCT03530696

Locations: 🇺🇸
Yale Cancer Center, New Haven, Connecticut, United States
🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
JPS Health Network, Fort Worth, Texas, United States

and more 13 locations

Effects of Freeze Dried Strawberry Powder Supplementation on Cardiovascular Risk Factors and Gut Microbiome

Not Applicable

Terminated

Conditions: Cardiovascular Risk Factor

Interventions: Dietary Supplement: Strawberry powder
Dietary Supplement: Placebo powder

First Posted Date: 2018-05-14

Last Posted Date: 2024-02-15

Lead Sponsor: University of Arizona

Target Recruit Count: 1

Registration Number: NCT03522974

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma

Not Applicable

Completed

Conditions: Prostate Adenocarcinoma

Interventions: Diagnostic Test: F-18 fluciclovine-PET/CT scan

First Posted Date: 2018-04-12

Last Posted Date: 2022-08-16

Lead Sponsor: University of Arizona

Target Recruit Count: 15

Registration Number: NCT03496844

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

Post-chemotherapy Symptom Management SMART

Not Applicable

Completed

Conditions: Cancer

Interventions: Behavioral: Start with SMSH alone
Behavioral: Start with SMSH+TIPC

First Posted Date: 2018-04-11

Last Posted Date: 2023-10-19

Lead Sponsor: University of Arizona

Target Recruit Count: 498

Registration Number: NCT03494166

Locations: 🇺🇸
Cancer Center at St. Joseph's, Phoenix, Arizona, United States
🇺🇸
University of Arizona, Tucson, Arizona, United States

Postoperative subQ Pain Control for Spinal Fusion Surgery

Phase 2

Completed

Conditions: Spine Fusion
Surgery
Pain, Postoperative

Interventions: Drug: 0.25% Marcaine at 2ml/hr and pain medications
Device: Placement of OnQ Drug pump

First Posted Date: 2018-03-26

Last Posted Date: 2022-05-26

Lead Sponsor: University of Arizona

Target Recruit Count: 11

Registration Number: NCT03476811

Locations: 🇺🇸
The University of Arizona, Tucson, Arizona, United States

Fycompa Titration Intervals and Effects on Retention Rate

Phase 4

Completed

Conditions: Epilepsy

Interventions: Drug: Perampanel Oral Tablet

First Posted Date: 2018-03-07

Last Posted Date: 2023-08-15

Lead Sponsor: University of Arizona

Target Recruit Count: 20

Registration Number: NCT03457129

Locations: 🇺🇸
Banner University Medical Center Phoenix, Phoenix, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy